Rising statin use and effect on ischemic stroke outcome - Wikidata - wikimedia - TriplyDB

Rising statin use and effect on ischemic stroke outcome

Rising statin use and effect on ischemic stroke outcome

http://www.wikidata.org/entity/Q24792305

about

Risk factors and in-hospital outcomes in stroke and myocardial infarction patients Statins in Acute Ischemic Stroke: A Systematic Review Recommendations and treatment strategies for the management of acute ischemic stroke.Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?Statins and clinical outcome of acute ischemic stroke: a systematic review Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins Pre and Post-stroke Use of Statins Improves Stroke Outcome.Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis.Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.Early mortality and functional outcome after acute stroke in Uganda: prospective study with 30 day follow-up Treatment with statins in the acute phase of ischemic stroke.The lower the better? Experiences from cardiovascular disease and stroke prevention.Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.Statin use before and after acute ischemic stroke onset improves neurological outcome.Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality.Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study.Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control study.

P2860

Q24792705-2D62673D-98F9-42BB-9FDF-62C2D8BB22FF Q26781913-7A8653A6-C173-4C3C-A72E-F7BF2571445B Q31153077-A411A4EE-72F7-48D7-9564-3BF09C150EA2 Q33611256-8A44AB6F-2D0F-4A7E-8355-1129486DC49B Q34199230-808580CA-35E0-4257-892E-37202AB07032 Q34264444-0E41F21F-0540-4690-B7F7-995554DFBB8A Q34432438-30527D83-BC70-4B44-8BEF-1557104F3524 Q34978642-AC050856-3C7F-4A06-9D77-ED7DD93442B4 Q35075417-F8391A24-DB6D-4383-8962-02AF8552F11F Q35991915-0361FF4C-266F-4063-9310-537CDAF4E704 Q36106811-70BD0702-083F-450A-AF04-C01BF28EAEA7 Q36546502-75E0707C-5854-4C77-BE5D-F4FBC38FC898 Q38101834-2A3C8984-E0D0-4F4F-8F76-6CF99803A44A Q43265095-E154F9B0-384A-4FE1-AA0C-2159235A6CC3 Q45903573-ECD39BD3-8F4E-4E15-ADB7-725C6CE8302E Q48461750-C930B23B-381E-4996-868B-F4F4A8915F57 Q48853156-79AE23D3-38D5-4CB5-A025-CE2C512A6B26

P2860

Rising statin use and effect on ischemic stroke outcome

http://www.wikidata.org/entity/Q24792305

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Rising statin use and effect on ischemic stroke outcome

@ast

Rising statin use and effect on ischemic stroke outcome

@en

Rising statin use and effect on ischemic stroke outcome

@nl

type

label

Rising statin use and effect on ischemic stroke outcome

@ast

Rising statin use and effect on ischemic stroke outcome

@en

Rising statin use and effect on ischemic stroke outcome

@nl

prefLabel

Rising statin use and effect on ischemic stroke outcome

@ast

Rising statin use and effect on ischemic stroke outcome

@en

Rising statin use and effect on ischemic stroke outcome

@nl

P1433

Q24792305-C2298D3F-8B80-4630-8D86-7FFBF94FE2E4

P1476

Q24792305-C35C7322-C4EB-4ED1-B40F-A5C3B1B3D2D7

P2093

Q24792305-14575D28-48A0-45D6-A977-3BC0AA0251CF

Q24792305-4E926FB3-BE90-498E-B35A-CE818159B27A

Q24792305-5D393E76-41FF-4663-AD1F-3618E240FAF2

Q24792305-709FE0BD-5D19-4F93-8EBC-0F3D41CBFD54

Q24792305-85CA1EBB-BB6C-4543-A29F-8F8F7DA839F2

Q24792305-B2C7CE58-0E33-4078-BB4A-355589807077

Q24792305-C14905A8-F22C-4BEC-90E6-B400DF0D2FF8

Q24792305-FF9AF2CE-B8DA-4A74-ABF2-00F45DA661BF

P2860

Q24792305-20A548F5-6CC2-42B5-8AC2-B60B142B6C3B

Q24792305-23C45AF2-E204-4CF8-ABD4-1F58F29922ED

Q24792305-2460AC43-C570-4BAF-B85F-560DDFE27E46

Q24792305-2C7DD7C4-6F98-4F62-A358-E00D5AE17E37

Q24792305-3656F72B-0B27-4A21-89D3-6AF5CD1B67BD

Q24792305-4ABD72FB-B489-4B56-AA0C-C00A3511F5F9

Q24792305-51E3EEB8-2C27-4FFA-A249-CF5991A86345

Q24792305-5774C429-078A-4B25-9C22-E70B89A319CB

Q24792305-5A8B3BAA-C92C-498C-A580-CB293C62B55C

Q24792305-6753B43F-62FF-48E1-9D32-58C1661B0BC1

P2888

Q24792305-BBBE8961-1E04-4BE5-9051-31B15300510F

P304

Q24792305-3C39822E-D585-4EE2-9026-263A499E4E17

P31

Q24792305-4ED191F4-8F18-4437-A136-F012F4DB733E

P356

Q24792305-EE8AC8BC-4762-4EAD-AA56-DE964044CCD9

P407

Q24792305-B247298F-019B-4455-9CDF-E25065FEE872

P433

Q24792305-4E898DA9-5523-4D89-8762-10B26B561B30

P478

Q24792305-42C1509B-0B84-4D78-9ADC-755C0054F155

P577

Q24792305-409B4B11-F333-420F-B6D8-02FD1A6D1C37

P5875

Q24792305-45AA9ED4-4489-4579-B5B7-8B097FC7233D

P6179

Q24792305-197E27AF-3583-46BE-BAEC-52395D252556

P698

Q24792305-5E3B4FD1-B84E-46BC-AF49-601AD57C75AC

P932

Q24792305-7FD2B2F1-A6FE-470C-9553-9D41BCE6CEA1

P356

P1433

P1476

Rising statin use and effect on ischemic stroke outcome

@en

P2093

Alison E Baird

http://www.w3.org/2001/XMLSchema#string

James Dambrosia

http://www.w3.org/2001/XMLSchema#string

Joseph Haymore

http://www.w3.org/2001/XMLSchema#string

Julio Chalela

http://www.w3.org/2001/XMLSchema#string

Lisa Davis

http://www.w3.org/2001/XMLSchema#string

Mustapha Ezzeddine

http://www.w3.org/2001/XMLSchema#string

Steven Warach

http://www.w3.org/2001/XMLSchema#string

Sung Sug Yoon

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker

Early statin initiation and outcomes in patients with acute coronary syndromes

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Direct vascular effects of HMG-CoA reductase inhibitors.

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-2-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8664408

http://www.w3.org/2001/XMLSchema#string

P6179

1050677315

http://www.w3.org/2001/XMLSchema#string

P698

15035663

http://www.w3.org/2001/XMLSchema#string

P932

395844

http://www.w3.org/2001/XMLSchema#string